These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 206196)

  • 41. [Biological parameters of a standardized tumor model for chemotherapeutical and toxicological testing (author's transl)].
    Fichtner I; Arnold W; Pehl E
    Arch Geschwulstforsch; 1979; 49(5):391-407. PubMed ID: 518249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A.
    Venditti JM; Johnson RK
    Recent Results Cancer Res; 1978; 63():49-57. PubMed ID: 705014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The effect of olivomycin on nucleic, amino acid and energy metabolism].
    Glushakova NE; Taranovich GL
    Antibiotiki; 1965 Sep; 10(9):804-8. PubMed ID: 5872777
    [No Abstract]   [Full Text] [Related]  

  • 44. The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
    Goldin A; Venditti JM; Geran R
    Invest New Drugs; 1985; 3(1):3-21. PubMed ID: 3886588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Interaction of sibiromycin with soluble chromatin from the cells of murine NK/LI lymphadenosis].
    Loz'mian LI
    Antibiotiki; 1978 Nov; 23(11):1015-7. PubMed ID: 581439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of VER I, synthetic derivative of verucarine E, on the growth of transplantable sarcoma 180 in mice].
    Nowak HF
    Patol Pol; 1976; 27(2):115-25. PubMed ID: 934707
    [No Abstract]   [Full Text] [Related]  

  • 47. Peplomycin-induced DNA repair synthesis in permeable mouse ascites sarcoma cells.
    Zhang B; Watanabe S; Akiyama K; Li T; Fukushima K; Tsutsui K; Seki S
    Acta Med Okayama; 1991 Apr; 45(2):89-94. PubMed ID: 1714230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Screening of antineoplastic antibiotics inhibiting nucleic acid synthesis].
    Ivanitskaia LP; Makukho LV; Klitsunova NV; Rossolimo OK
    Antibiotiki; 1971 Feb; 16(2):115-9. PubMed ID: 5557384
    [No Abstract]   [Full Text] [Related]  

  • 49. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Actinomycin D effects on nucleic acids during tumor regression.
    Schwartz HS; Sodergren JE
    Cancer Res; 1968 Mar; 28(3):445-51. PubMed ID: 5238558
    [No Abstract]   [Full Text] [Related]  

  • 51. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problem of screening of antineoplastic drugs in tissue and cell cultures].
    Dobrynin IaV
    Eksp Onkol; 1985; 7(2):9-15. PubMed ID: 4006851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trial of bisantrene in advanced colorectal carcinoma.
    Ahmed T; Kemeny NE; Michaelson RA; Harper HD
    Cancer Treat Rep; 1983 Mar; 67(3):307-8. PubMed ID: 6831479
    [No Abstract]   [Full Text] [Related]  

  • 55. [Molecular and cellular bases of cytostatic therapy].
    Schindler R
    Schweiz Med Wochenschr; 1974 Feb; 104(8):271-4. PubMed ID: 4814678
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of homologous tumor DNA on the evolution of SV40-induced hamster sarcoma.
    Nastac E; Stoian M; Iosipenco M; Suru M; Hozoc M; Repanovici R
    Virologie; 1985; 36(1):31-6. PubMed ID: 2988193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
    Perez-Soler R; Priebe W
    Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell synchronization in solid tumors.
    Schumann J; Ehring F; Gohde W
    Recent Results Cancer Res; 1975; (52):206-14. PubMed ID: 64995
    [No Abstract]   [Full Text] [Related]  

  • 60. [Seasonal changes in the rate of development and sensitivity of lymphosarcoma to olivomycin in male and female albino mice].
    Averbukh LA; Shorin VA
    Antibiotiki; 1971 Mar; 16(3):224-8. PubMed ID: 5109158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.